- Home
- SCWO vs FGEN Comparison
SCWO vs FGEN Comparison
Compare SCWO & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCWO
- FGEN
- Stock Information
- Founded
- SCWO 2021
- FGEN 1993
- Country
- SCWO United States
- FGEN United States
- Employees
- SCWO N/A
- FGEN N/A
- Industry
- SCWO Environmental Services
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- SCWO Utilities
- FGEN Health Care
- Exchange
- SCWO Nasdaq
- FGEN Nasdaq
- Market Cap
- SCWO 39.9M
- FGEN 33.5M
- IPO Year
- SCWO N/A
- FGEN 2014
- Fundamental
- Price
- SCWO $0.48
- FGEN $0.29
- Analyst Decision
- SCWO
- FGEN Strong Buy
- Analyst Count
- SCWO 0
- FGEN 1
- Target Price
- SCWO N/A
- FGEN $10.00
- AVG Volume (30 Days)
- SCWO 3.2M
- FGEN 727.7K
- Earning Date
- SCWO 05-15-2025
- FGEN 05-12-2025
- Dividend Yield
- SCWO N/A
- FGEN N/A
- EPS Growth
- SCWO N/A
- FGEN N/A
- EPS
- SCWO N/A
- FGEN N/A
- Revenue
- SCWO $673,267.00
- FGEN $6,996,000.00
- Revenue This Year
- SCWO $5,945.19
- FGEN $232.81
- Revenue Next Year
- SCWO $106.82
- FGEN $9.16
- P/E Ratio
- SCWO N/A
- FGEN N/A
- Revenue Growth
- SCWO 161.19
- FGEN N/A
- 52 Week Low
- SCWO $0.25
- FGEN $0.18
- 52 Week High
- SCWO $1.99
- FGEN $1.53
- Technical
- Relative Strength Index (RSI)
- SCWO 64.99
- FGEN 37.51
- Support Level
- SCWO $0.40
- FGEN $0.29
- Resistance Level
- SCWO $0.68
- FGEN $0.34
- Average True Range (ATR)
- SCWO 0.07
- FGEN 0.02
- MACD
- SCWO 0.02
- FGEN -0.00
- Stochastic Oscillator
- SCWO 42.88
- FGEN 0.66
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.